Thalidomide induction of bone marrow transplantation tolerance.
D000616:Aminoglutethimide / Q000627:therapeutic use; D000818:Animals; D016026:Bone Marrow Transplantation; D005260:Female; D005453:Fluorescence; D006086:Graft vs Host Disease / Q000188:drug therapy / Q000517:prevention & control; D007165:Immunosuppression Therapy; D010797:Phthalimides / Q000627:therapeutic use; D051381:Rats; D011912:Rats, Inbred ACI; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011920:Rats, Inbred WF; D013601:T-Lymphocytes / Q000378:metabolism; D013792:Thalidomide / Q000378:metabolism / Q000627:therapeutic use*
D010797:Phthalimides; D000616:Aminoglutethimide; C037431:phthalimide; D013792:Thalidomide